ACHV · Achieve Life Sciences, Inc. · Debt
$6.51
+0.00 (+0.00%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$675.04M
Shares
102.90M
Volume · Oct 21
2.47M
Avg daily vol (3M)
1.44M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 36,000 | 10-Q filed 2026-08-11 |
| Current portion of convertible debt | 2026-06-30 | USD 7,454,000 | 10-Q filed 2026-08-11 |
| Noncurrent convertible debt | 2026-06-30 | USD 7,458,000 | 10-Q filed 2026-08-11 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
949858
CUSIP
004468500
13F (30d)
11 filings
11 filers
Visit website
Investor relations